I have done a lot of research on medical imaging companies or...

I have done a lot of research on medical imaging companies or med related companies on the asx, many of them are really great, some already FDA approved, some already commercialised and raking in profits from sales. But the thing is, most of them can only be valued at a 500 million market cap at best, based on what their product can achieve in terms of application in the medical world, sales, etc. From memory most of them as far as I can remember are getting million dollar contracts at best. One of the few biotechs I found on the asx that could transform medicine was IBX. IBX is one of the few companies that if successful in delivering their product as promised, well they hold a product that can bring in billions in revenue, their product can eventually kick out other types of imaging out of hospitals and into the museum. That's why yes some might say IBX is overvalued at a 100M market cap with no commercialised product, but if you think about it, if 3 years down the line IBX is a 5 billion dollar company, who would not have loved to pick up some shares at 10c?